113 related articles for article (PubMed ID: 24667177)
21. Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer.
Ye L; Lin C; Wang X; Li Q; Li Y; Wang M; Zhao Z; Wu X; Shi D; Xiao Y; Ren L; Jian Y; Yang M; Ou R; Deng G; Ouyang Y; Chen X; Li J; Song L
EMBO Mol Med; 2019 Dec; 11(12):e10638. PubMed ID: 31657150
[TBL] [Abstract][Full Text] [Related]
22. Lymphatic metastasis-related TBL1XR1 enhances stemness and metastasis in gastric cancer stem-like cells by activating ERK1/2-SOX2 signaling.
Lu J; Bang H; Kim SM; Cho SJ; Ashktorab H; Smoot DT; Zheng CH; Ryeom SW; Yoon SS; Yoon C; Lee JH
Oncogene; 2021 Feb; 40(5):922-936. PubMed ID: 33288885
[TBL] [Abstract][Full Text] [Related]
23. TBL1XR1 as a potential therapeutic target that promotes epithelial-mesenchymal transition in lung squamous cell carcinoma.
Zhao Y; Lin H; Jiang J; Ge M; Liang X
Exp Ther Med; 2019 Jan; 17(1):91-98. PubMed ID: 30651768
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of Esophageal Squamous Cell Carcinoma.
Abnet CC; Arnold M; Wei WQ
Gastroenterology; 2018 Jan; 154(2):360-373. PubMed ID: 28823862
[TBL] [Abstract][Full Text] [Related]
25. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Bray F; Ferlay J; Soerjomataram I; Siegel RL; Torre LA; Jemal A
CA Cancer J Clin; 2018 Nov; 68(6):394-424. PubMed ID: 30207593
[TBL] [Abstract][Full Text] [Related]
26. HSF1 facilitates the multistep process of lymphatic metastasis in bladder cancer via a novel PRMT5-WDR5-dependent transcriptional program.
Huang M; Dong W; Xie R; Wu J; Su Q; Li W; Yao K; Chen Y; Zhou Q; Zhang Q; Li W; Cheng L; Peng S; Chen S; Huang J; Chen X; Lin T
Cancer Commun (Lond); 2022 May; 42(5):447-470. PubMed ID: 35434944
[TBL] [Abstract][Full Text] [Related]
27. Tumor-derived exosomal BCYRN1 activates WNT5A/VEGF-C/VEGFR3 feedforward loop to drive lymphatic metastasis of bladder cancer.
Zheng H; Chen C; Luo Y; Yu M; He W; An M; Gao B; Kong Y; Ya Y; Lin Y; Li Y; Xie K; Huang J; Lin T
Clin Transl Med; 2021 Jul; 11(7):e497. PubMed ID: 34323412
[TBL] [Abstract][Full Text] [Related]
28. HOXC10 upregulation confers resistance to chemoradiotherapy in ESCC tumor cells and predicts poor prognosis.
Suo D; Wang Z; Li L; Chen Q; Zeng T; Liu R; Yun J; Guan XY; Li Y
Oncogene; 2020 Aug; 39(32):5441-5454. PubMed ID: 32587398
[TBL] [Abstract][Full Text] [Related]
29. Transducin (β)-like 1 X-linked receptor 1 promotes gastric cancer progression via the ERK1/2 pathway.
Zhou Q; Wang X; Yu Z; Wu X; Chen X; Li J; Zhu Z; Liu B; Su L
Oncogene; 2017 Mar; 36(13):1873-1886. PubMed ID: 27694893
[TBL] [Abstract][Full Text] [Related]
30. TBLR1 is a novel prognostic marker and promotes epithelial-mesenchymal transition in cervical cancer.
Wang J; Ou J; Guo Y; Dai T; Li X; Liu J; Xia M; Liu L; He M
Br J Cancer; 2014 Jul; 111(1):112-24. PubMed ID: 24874481
[TBL] [Abstract][Full Text] [Related]
31. IL-1β promotes esophageal squamous cell carcinoma growth and metastasis through FOXO3A by activating the PI3K/AKT pathway.
Chen S; Yang Y; Zheng Z; Zhang M; Chen X; Xiao N; Liu H
Cell Death Discov; 2024 May; 10(1):238. PubMed ID: 38762529
[TBL] [Abstract][Full Text] [Related]
32. Domperidone inhibits cell proliferation via targeting MEK and CDK4 in esophageal squamous cell carcinoma.
Yuan Q; Shi Y; Zhang Y; Shi Y; Hussain Z; Zhao J; Jiang Y; Qiao Y; Guo Y; Lu J; Dong Z; Dong Z; Wang J; Liu K
Cancer Cell Int; 2024 Mar; 24(1):114. PubMed ID: 38528618
[TBL] [Abstract][Full Text] [Related]
33. Two decades of a protooncogene TBL1XR1: from a transcription modulator to cancer therapeutic target.
Du R; Li K; Guo K; Chen Z; Zhao X; Han L; Bian H
Front Oncol; 2024; 14():1309687. PubMed ID: 38347836
[TBL] [Abstract][Full Text] [Related]
34. Androgen Receptor/AP-1 Activates
Cai J; Huang F; Gao W; Gong T; Chen H; Liu Z
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136265
[TBL] [Abstract][Full Text] [Related]
35. Nicotinamide adenine dinucleotide kinase promotes lymph node metastasis of NSCLC via activating ID1 expression through BMP pathway.
Zeng Z; Gao J; Chen T; Zhang Z; Li M; Fan Q; Liu G; Li X; Li Z; Zhong C; Yao F; Sun L; Deng Y; Li M
Int J Biol Sci; 2023; 19(10):3184-3199. PubMed ID: 37416767
[TBL] [Abstract][Full Text] [Related]
36. CRIP1 Reshapes the Gastric Cancer Microenvironment to Facilitate Development of Lymphatic Metastasis.
Wu Z; Qu B; Yuan M; Liu J; Zhou C; Sun M; Guo Z; Zhang Y; Song Y; Wang Z
Adv Sci (Weinh); 2023 Sep; 10(26):e2303246. PubMed ID: 37409440
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of ITGA5 inhibits lymphangiogenesis and cell migration and invasion in male laryngeal squamous cell carcinoma.
Wang X; Huang J; You R; Hou D; Liu J; Wu L; Yao M; Yang F; Huang H
Protoplasma; 2023 Nov; 260(6):1569-1580. PubMed ID: 37338646
[TBL] [Abstract][Full Text] [Related]
38. Exosomal circ_0026611 contributes to lymphangiogenesis by reducing PROX1 acetylation and ubiquitination in human lymphatic endothelial cells (HLECs).
Yao W; Jia X; Zhu L; Xu L; Zhang Q; Xia T; Wei L
Cell Mol Biol Lett; 2023 Feb; 28(1):13. PubMed ID: 36803975
[TBL] [Abstract][Full Text] [Related]
39. Exosomal miR-10527-5p Inhibits Migration, Invasion, Lymphangiogenesis and Lymphatic Metastasis by Affecting Wnt/β-Catenin Signaling via Rab10 in Esophageal Squamous Cell Carcinoma.
Xiao Z; Feng X; Zhou Y; Li P; Luo J; Zhang W; Zhou J; Zhao J; Wang D; Wang Y; Tian Z; Zhao X
Int J Nanomedicine; 2023; 18():95-114. PubMed ID: 36636641
[TBL] [Abstract][Full Text] [Related]
40. 3D CRISPR screen in prostate cancer cells reveals PARP inhibitor sensitization through TBL1XR1-SMC3 interaction.
Zhang H; Gao H; Gu Y; John A; Wei L; Huang M; Yu J; Adeosun AA; Weinshilboum RM; Wang L
Front Oncol; 2022; 12():999302. PubMed ID: 36523978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
